The U.S. Food and Drug Administration (FDA) on Thursday gave approval to a drug manufactured by Marathon Pharmaceuticals to treat Duchenne’s muscular dystrophy (DMD), a devastating muscle disease that usually affects boys.

Source: FDA approves $89,000 drug to treat Duchenne’s Muscular dystrophy

Advertisements